Global Antibody Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 (Based on 2020 COVID-19 Worldwide Spread)
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The Antibody market is expected to grow from USD X.X million in 2021 to USD X.X million by 2027, at a CAGR of X.X% during the forecast period. The global Antibody market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antibody market. The report focuses on well-known providers in the global Antibody industry, market segments, competition, and the macro environment.
Under COVID-19 Outbreak, how the Antibody Industry will develop is also analyzed in detail in Chapter 1.7 of the report.
In Chapter 2.4, we analyzed industry trends in the context of COVID-19.
In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.
In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.
In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.
A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.
Key players in the global Antibody market covered in Chapter 4:
Eppendorf AG
Sartorius AG
INTEGRA Biosciences AG
Cellab GmbH
Thermo Fisher Scientific, Inc
Sigma-Aldrich Corporation
Merck KGaA
GE Healthcare
FiberCell Systems Inc
Pall Corporation
In Chapter 11 and 13.3, on the basis of types, the Antibody market from 2016 to 2027 is primarily split into:
Monoclonal Antibodies
Polyclonal Antibodies
Antibody-drug Complexes (ADCs)
In Chapter 12 and 13.4, on the basis of applications, the Antibody market from 2016 to 2027 covers:
Therapeutic
Research
Diagnostic
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2016-2027) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:
North America (Covered in Chapter 6 and 13)
United States
Canada
Mexico
Europe (Covered in Chapter 7 and 13)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8 and 13)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 9 and 13)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 10 and 13)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Period: 2021-2027
Table of Content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Regulatory Scenario by Region/Country
1.4 Market Investment Scenario Strategic
1.5 Market Analysis by Type
1.5.1 Global Antibody Market Share by Type (2021-2027)
1.5.2 Monoclonal Antibodies
1.5.3 Polyclonal Antibodies
1.5.4 Antibody-drug Complexes (ADCs)
1.6 Market by Application
1.6.1 Global Antibody Market Share by Application (2021-2027)
1.6.2 Therapeutic
1.6.3 Research
1.6.4 Diagnostic
1.7 Antibody Industry Development Trends under COVID-19 Outbreak
1.7.1 Global COVID-19 Status Overview
1.7.2 Influence of COVID-19 Outbreak on Antibody Industry Development
2. Global Market Growth Trends
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
2.3 Industry News and Policies by Regions
2.3.1 Industry News
2.3.2 Industry Policies
2.4 Industry Trends Under COVID-19
3 Value Chain of Antibody Market
3.1 Value Chain Status
3.2 Antibody Manufacturing Cost Structure Analysis
3.2.1 Production Process Analysis
3.2.2 Manufacturing Cost Structure of Antibody
3.2.3 Labor Cost of Antibody
3.2.3.1 Labor Cost of Antibody Under COVID-19
3.3 Sales and Marketing Model Analysis
3.4 Downstream Major Customer Analysis (by Region)
3.5 Value Chain Status Under COVID-19
4 Players Profiles
4.1 Eppendorf AG
4.1.1 Eppendorf AG Basic Information
4.1.2 Antibody Product Profiles, Application and Specification
4.1.3 Eppendorf AG Antibody Market Performance (2016-2021)
4.1.4 Eppendorf AG Business Overview
4.2 Sartorius AG
4.2.1 Sartorius AG Basic Information
4.2.2 Antibody Product Profiles, Application and Specification
4.2.3 Sartorius AG Antibody Market Performance (2016-2021)
4.2.4 Sartorius AG Business Overview
4.3 INTEGRA Biosciences AG
4.3.1 INTEGRA Biosciences AG Basic Information
4.3.2 Antibody Product Profiles, Application and Specification
4.3.3 INTEGRA Biosciences AG Antibody Market Performance (2016-2021)
4.3.4 INTEGRA Biosciences AG Business Overview
4.4 Cellab GmbH
4.4.1 Cellab GmbH Basic Information
4.4.2 Antibody Product Profiles, Application and Specification
4.4.3 Cellab GmbH Antibody Market Performance (2016-2021)
4.4.4 Cellab GmbH Business Overview
4.5 Thermo Fisher Scientific, Inc
4.5.1 Thermo Fisher Scientific, Inc Basic Information
4.5.2 Antibody Product Profiles, Application and Specification
4.5.3 Thermo Fisher Scientific, Inc Antibody Market Performance (2016-2021)
4.5.4 Thermo Fisher Scientific, Inc Business Overview
4.6 Sigma-Aldrich Corporation
4.6.1 Sigma-Aldrich Corporation Basic Information
4.6.2 Antibody Product Profiles, Application and Specification
4.6.3 Sigma-Aldrich Corporation Antibody Market Performance (2016-2021)
4.6.4 Sigma-Aldrich Corporation Business Overview
4.7 Merck KGaA
4.7.1 Merck KGaA Basic Information
4.7.2 Antibody Product Profiles, Application and Specification
4.7.3 Merck KGaA Antibody Market Performance (2016-2021)
4.7.4 Merck KGaA Business Overview
4.8 GE Healthcare
4.8.1 GE Healthcare Basic Information
4.8.2 Antibody Product Profiles, Application and Specification
4.8.3 GE Healthcare Antibody Market Performance (2016-2021)
4.8.4 GE Healthcare Business Overview
4.9 FiberCell Systems Inc
4.9.1 FiberCell Systems Inc Basic Information
4.9.2 Antibody Product Profiles, Application and Specification
4.9.3 FiberCell Systems Inc Antibody Market Performance (2016-2021)
4.9.4 FiberCell Systems Inc Business Overview
4.10 Pall Corporation
4.10.1 Pall Corporation Basic Information
4.10.2 Antibody Product Profiles, Application and Specification
4.10.3 Pall Corporation Antibody Market Performance (2016-2021)
4.10.4 Pall Corporation Business Overview
5 Global Antibody Market Analysis by Regions
5.1 Global Antibody Sales, Revenue and Market Share by Regions
5.1.1 Global Antibody Sales by Regions (2016-2021)
5.1.2 Global Antibody Revenue by Regions (2016-2021)
5.2 North America Antibody Sales and Growth Rate (2016-2021)
5.3 Europe Antibody Sales and Growth Rate (2016-2021)
5.4 Asia-Pacific Antibody Sales and Growth Rate (2016-2021)
5.5 Middle East and Africa Antibody Sales and Growth Rate (2016-2021)
5.6 South America Antibody Sales and Growth Rate (2016-2021)
6 North America Antibody Market Analysis by Countries
6.1 North America Antibody Sales, Revenue and Market Share by Countries
6.1.1 North America Antibody Sales by Countries (2016-2021)
6.1.2 North America Antibody Revenue by Countries (2016-2021)
6.1.3 North America Antibody Market Under COVID-19
6.2 United States Antibody Sales and Growth Rate (2016-2021)
6.2.1 United States Antibody Market Under COVID-19
6.3 Canada Antibody Sales and Growth Rate (2016-2021)
6.4 Mexico Antibody Sales and Growth Rate (2016-2021)
7 Europe Antibody Market Analysis by Countries
7.1 Europe Antibody Sales, Revenue and Market Share by Countries
7.1.1 Europe Antibody Sales by Countries (2016-2021)
7.1.2 Europe Antibody Revenue by Countries (2016-2021)
7.1.3 Europe Antibody Market Under COVID-19
7.2 Germany Antibody Sales and Growth Rate (2016-2021)
7.2.1 Germany Antibody Market Under COVID-19
7.3 UK Antibody Sales and Growth Rate (2016-2021)
7.3.1 UK Antibody Market Under COVID-19
7.4 France Antibody Sales and Growth Rate (2016-2021)
7.4.1 France Antibody Market Under COVID-19
7.5 Italy Antibody Sales and Growth Rate (2016-2021)
7.5.1 Italy Antibody Market Under COVID-19
7.6 Spain Antibody Sales and Growth Rate (2016-2021)
7.6.1 Spain Antibody Market Under COVID-19
7.7 Russia Antibody Sales and Growth Rate (2016-2021)
7.7.1 Russia Antibody Market Under COVID-19
8 Asia-Pacific Antibody Market Analysis by Countries
8.1 Asia-Pacific Antibody Sales, Revenue and Market Share by Countries
8.1.1 Asia-Pacific Antibody Sales by Countries (2016-2021)
8.1.2 Asia-Pacific Antibody Revenue by Countries (2016-2021)
8.1.3 Asia-Pacific Antibody Market Under COVID-19
8.2 China Antibody Sales and Growth Rate (2016-2021)
8.2.1 China Antibody Market Under COVID-19
8.3 Japan Antibody Sales and Growth Rate (2016-2021)
8.3.1 Japan Antibody Market Under COVID-19
8.4 South Korea Antibody Sales and Growth Rate (2016-2021)
8.4.1 South Korea Antibody Market Under COVID-19
8.5 Australia Antibody Sales and Growth Rate (2016-2021)
8.6 India Antibody Sales and Growth Rate (2016-2021)
8.6.1 India Antibody Market Under COVID-19
8.7 Southeast Asia Antibody Sales and Growth Rate (2016-2021)
8.7.1 Southeast Asia Antibody Market Under COVID-19
9 Middle East and Africa Antibody Market Analysis by Countries
9.1 Middle East and Africa Antibody Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Antibody Sales by Countries (2016-2021)
9.1.2 Middle East and Africa Antibody Revenue by Countries (2016-2021)
9.1.3 Middle East and Africa Antibody Market Under COVID-19
9.2 Saudi Arabia Antibody Sales and Growth Rate (2016-2021)
9.3 UAE Antibody Sales and Growth Rate (2016-2021)
9.4 Egypt Antibody Sales and Growth Rate (2016-2021)
9.5 Nigeria Antibody Sales and Growth Rate (2016-2021)
9.6 South Africa Antibody Sales and Growth Rate (2016-2021)
10 South America Antibody Market Analysis by Countries
10.1 South America Antibody Sales, Revenue and Market Share by Countries
10.1.1 South America Antibody Sales by Countries (2016-2021)
10.1.2 South America Antibody Revenue by Countries (2016-2021)
10.1.3 South America Antibody Market Under COVID-19
10.2 Brazil Antibody Sales and Growth Rate (2016-2021)
10.2.1 Brazil Antibody Market Under COVID-19
10.3 Argentina Antibody Sales and Growth Rate (2016-2021)
10.4 Columbia Antibody Sales and Growth Rate (2016-2021)
10.5 Chile Antibody Sales and Growth Rate (2016-2021)
11 Global Antibody Market Segment by Types
11.1 Global Antibody Sales, Revenue and Market Share by Types (2016-2021)
11.1.1 Global Antibody Sales and Market Share by Types (2016-2021)
11.1.2 Global Antibody Revenue and Market Share by Types (2016-2021)
11.2 Monoclonal Antibodies Sales and Price (2016-2021)
11.3 Polyclonal Antibodies Sales and Price (2016-2021)
11.4 Antibody-drug Complexes (ADCs) Sales and Price (2016-2021)
12 Global Antibody Market Segment by Applications
12.1 Global Antibody Sales, Revenue and Market Share by Applications (2016-2021)
12.1.1 Global Antibody Sales and Market Share by Applications (2016-2021)
12.1.2 Global Antibody Revenue and Market Share by Applications (2016-2021)
12.2 Therapeutic Sales, Revenue and Growth Rate (2016-2021)
12.3 Research Sales, Revenue and Growth Rate (2016-2021)
12.4 Diagnostic Sales, Revenue and Growth Rate (2016-2021)
13 Antibody Market Forecast by Regions (2021-2027)
13.1 Global Antibody Sales, Revenue and Growth Rate (2021-2027)
13.2 Antibody Market Forecast by Regions (2021-2027)
13.2.1 North America Antibody Market Forecast (2021-2027)
13.2.2 Europe Antibody Market Forecast (2021-2027)
13.2.3 Asia-Pacific Antibody Market Forecast (2021-2027)
13.2.4 Middle East and Africa Antibody Market Forecast (2021-2027)
13.2.5 South America Antibody Market Forecast (2021-2027)
13.3 Antibody Market Forecast by Types (2021-2027)
13.4 Antibody Market Forecast by Applications (2021-2027)
13.5 Antibody Market Forecast Under COVID-19
14 Appendix
14.1 Methodology
14.2 Research Data Source
List of Tables and Figures
Table Global Antibody Market Size Growth Rate by Type (2021-2027)
Figure Global Antibody Market Share by Type in 2020 & 2026
Figure Monoclonal Antibodies Features
Figure Polyclonal Antibodies Features
Figure Antibody-drug Complexes (ADCs) Features
Table Global Antibody Market Size Growth by Application (2021-2027)
Figure Global Antibody Market Share by Application in 2020 & 2026
Figure Therapeutic Description
Figure Research Description
Figure Diagnostic Description
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Antibody Industry Development
Table SWOT Analysis
Figure Porter's Five Forces Analysis
Figure Global Antibody Market Size and Growth Rate 2016-2027
Table Industry News
Table Industry Policies
Figure Value Chain Status of Antibody
Figure Production Process of Antibody
Figure Manufacturing Cost Structure of Antibody
Figure Major Company Analysis (by Business Distribution Base, by Product Type)
Table Downstream Major Customer Analysis (by Region)
Table Eppendorf AG Profile
Table Eppendorf AG Production, Value, Price, Gross Margin 2016-2021
Table Sartorius AG Profile
Table Sartorius AG Production, Value, Price, Gross Margin 2016-2021
Table INTEGRA Biosciences AG Profile
Table INTEGRA Biosciences AG Production, Value, Price, Gross Margin 2016-2021
Table Cellab GmbH Profile
Table Cellab GmbH Production, Value, Price, Gross Margin 2016-2021
Table Thermo Fisher Scientific, Inc Profile
Table Thermo Fisher Scientific, Inc Production, Value, Price, Gross Margin 2016-2021
Table Sigma-Aldrich Corporation Profile
Table Sigma-Aldrich Corporation Production, Value, Price, Gross Margin 2016-2021
Table Merck KGaA Profile
Table Merck KGaA Production, Value, Price, Gross Margin 2016-2021
Table GE Healthcare Profile
Table GE Healthcare Production, Value, Price, Gross Margin 2016-2021
Table FiberCell Systems Inc Profile
Table FiberCell Systems Inc Production, Value, Price, Gross Margin 2016-2021
Table Pall Corporation Profile
Table Pall Corporation Production, Value, Price, Gross Margin 2016-2021
Figure Global Antibody Sales and Growth Rate (2016-2021)
Figure Global Antibody Revenue ($) and Growth (2016-2021)
Table Global Antibody Sales by Regions (2016-2021)
Table Global Antibody Sales Market Share by Regions (2016-2021)
Table Global Antibody Revenue ($) by Regions (2016-2021)
Table Global Antibody Revenue Market Share by Regions (2016-2021)
Table Global Antibody Revenue Market Share by Regions in 2016
Table Global Antibody Revenue Market Share by Regions in 2020
Figure North America Antibody Sales and Growth Rate (2016-2021)
Figure Europe Antibody Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Antibody Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Antibody Sales and Growth Rate (2016-2021)
Figure South America Antibody Sales and Growth Rate (2016-2021)
Figure North America Antibody Revenue ($) and Growth (2016-2021)
Table North America Antibody Sales by Countries (2016-2021)
Table North America Antibody Sales Market Share by Countries (2016-2021)
Figure North America Antibody Sales Market Share by Countries in 2016
Figure United States Antibody Sales and Growth Rate (2016-2021)
Figure Canada Antibody Sales and Growth Rate (2016-2021)
Figure Mexico Antibody Sales and Growth (2016-2021)
Figure Europe Antibody Revenue ($) Growth (2016-2021)
Table Europe Antibody Sales by Countries (2016-2021)
Table Europe Antibody Sales Market Share by Countries (2016-2021)
Figure Germany Antibody Sales and Growth Rate (2016-2021)
Figure UK Antibody Sales and Growth Rate (2016-2021)
Figure France Antibody Sales and Growth Rate (2016-2021)
Figure Italy Antibody Sales and Growth Rate (2016-2021)
Figure Spain Antibody Sales and Growth Rate (2016-2021)
Figure Russia Antibody Sales and Growth Rate (2016-2021)
Figure Asia-Pacific Antibody Revenue ($) and Growth (2016-2021)
Table Asia-Pacific Antibody Sales by Countries (2016-2021)
Table Asia-Pacific Antibody Sales Market Share by Countries (2016-2021)
Figure China Antibody Sales and Growth Rate (2016-2021)
Figure Japan Antibody Sales and Growth Rate (2016-2021)
Figure South Korea Antibody Sales and Growth Rate (2016-2021)
Figure Australia Antibody Sales and Growth Rate (2016-2021)
Figure India Antibody Sales and Growth Rate (2016-2021)
Figure Southeast Asia Antibody Sales and Growth Rate (2016-2021)
Figure Middle East and Africa Antibody Revenue ($) and Growth (2016-2021)
Table Middle East and Africa Antibody Sales by Countries (2016-2021)
Table Middle East and Africa Antibody Sales Market Share by Countries (2016-2021)
Figure Saudi Arabia Antibody Sales and Growth Rate (2016-2021)
Figure UAE Antibody Sales and Growth Rate (2016-2021)
Figure Egypt Antibody Sales and Growth Rate (2016-2021)
Figure Nigeria Antibody Sales and Growth Rate (2016-2021)
Figure South Africa Antibody Sales and Growth Rate (2016-2021)
Figure South America Antibody Revenue ($) and Growth (2016-2021)
Figure Brazil Antibody Sales and Growth Rate (2016-2021)
Figure Argentina Antibody Sales and Growth Rate (2016-2021)
Figure Columbia Antibody Sales and Growth Rate (2016-2021)
Figure Chile Antibody Sales and Growth Rate (2016-2021)
Table Global Antibody Sales by Types (2016-2021)
Table Global Antibody Revenue ($) by Types (2016-2021)
Figure Global Monoclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Global Monoclonal Antibodies Price (2016-2021)
Figure Global Polyclonal Antibodies Sales and Growth Rate (2016-2021)
Figure Global Polyclonal Antibodies Price (2016-2021)
Figure Global Antibody-drug Complexes (ADCs) Sales and Growth Rate (2016-2021)
Figure Global Antibody-drug Complexes (ADCs) Price (2016-2021)
Table Global Antibody Sales by Applications (2016-2021)
Table Global Antibody Sales Share by Applications (2016-2021)
Figure Global Therapeutic Sales and Growth Rate (2016-2021)
Figure Global Therapeutic Revenue and Growth Rate (2016-2021)
Figure Global Research Sales and Growth Rate (2016-2021)
Figure Global Research Revenue and Growth Rate (2016-2021)
Figure Global Diagnostic Sales and Growth Rate (2016-2021)
Figure Global Diagnostic Revenue and Growth Rate (2016-2021)
Figure Global Antibody Sales and Growth Rate (2021-2027)
Figure Global Antibody Revenue ($) and Growth Rate (2021-2027)
Table Global Antibody Sales Forecast by Regions (2021-2027)
Table Global Antibody Revenue Forecast by Regions (2021-2027)
Figure North America Antibody Sales Forecast (2021-2027)
Figure North America Antibody Revenue Forecast (2021-2027)
Figure Europe Antibody Sales Forecast (2021-2027)
Figure Europe Antibody Revenue Forecast (2021-2027)
Figure Asia-Pacific Antibody Sales Forecast (2021-2027)
Figure Asia-Pacific Antibody Revenue Forecast (2021-2027)
Figure Middle East and Africa Antibody Sales Forecast (2021-2027)
Figure Middle East and Africa Antibody Revenue Forecast (2021-2027)
Figure South America Antibody Sales Forecast (2021-2027)
Figure South America Antibody Revenue Forecast (2021-2027)
Table Global Antibody Sales Forecast by Types (2021-2027)
Table Global Antibody Sales Market Share Forecast by Types (2021-2027)
Table Global Antibody Revenue Market Share Forecast by Types (2021-2027)
Table Global Antibody Sales Market Share Forecast by Applications (2021-2027)
Table Global Antibody Revenue Forecast by Applications (2021-2027)
Table Global Antibody Revenue Market Share Forecast by Applications (2021-2027)
Research Methodology:
Antibody Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|